• Return to Headlines

Watch for Continued Losses in Shares of Celldex Therapeu (CLDX)

By David Diaz

Shares of Celldex Therapeu (NASDAQ:CLDX) traded today at $0.99, breaking its 52-week low. So far today approximately 12.4 million shares have been exchanged, as compared to an average 30-day volume of 3.6 million shares.

In the past 52 weeks, Celldex Therapeu share prices have been bracketed by a current low of $0.99 and a high of $5.02 and are now at $1.00. Over the past week, the 200-day moving average (MA) has gone down 3.7% while the 50-day MA has declined 5.1%.

Potential upside of 700.0% exists for Celldex Therapeu, based on a current level of $1.00 and analysts' average consensus price target of $8.00. The stock should find initial resistance at its 50-day moving average (MA) of $4.47 and further resistance at its 200-day MA of $11.72.

Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.

SmarTrend is monitoring the recent change of momentum in Celldex Therapeu. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Celldex Therapeu in search of a potential trend change.

Keywords: 52 week high/lows celldex therapeu

Ticker(s): CLDX